These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 8302824

  • 1. Identification of the MAGE-1 gene product by monoclonal and polyclonal antibodies.
    Chen YT, Stockert E, Chen Y, Garin-Chesa P, Rettig WJ, van der Bruggen P, Boon T, Old LJ.
    Proc Natl Acad Sci U S A; 1994 Feb 01; 91(3):1004-8. PubMed ID: 8302824
    [Abstract] [Full Text] [Related]

  • 2. Monoclonal antibodies against recombinant-MAGE-1 protein identify a cross-reacting 72-kDa antigen which is co-expressed with MAGE-1 protein in melanoma cells.
    Carrel S, Schreyer M, Spagnoli G, Cerottini JC, Rimoldi D.
    Int J Cancer; 1996 Jul 29; 67(3):417-22. PubMed ID: 8707418
    [Abstract] [Full Text] [Related]

  • 3. cDNA and protein characterization of human MAGE-10.
    Rimoldi D, Salvi S, Reed D, Coulie P, Jongeneel VC, De Plaen E, Brasseur F, Rodriguez AM, Boon T, Cerottini JC.
    Int J Cancer; 1999 Sep 09; 82(6):901-7. PubMed ID: 10446460
    [Abstract] [Full Text] [Related]

  • 4. Identification and intracellular location of MAGE-3 gene product.
    Kocher T, Schultz-Thater E, Gudat F, Schaefer C, Casorati G, Juretic A, Willimann T, Harder F, Heberer M, Spagnoli GC.
    Cancer Res; 1995 Jun 01; 55(11):2236-9. PubMed ID: 7757970
    [Abstract] [Full Text] [Related]

  • 5. MAGE-1 gene product is a cytoplasmic protein.
    Schultz-Thater E, Juretic A, Dellabona P, Lüscher U, Siegrist W, Harder F, Heberer M, Zuber M, Spagnoli GC.
    Int J Cancer; 1994 Nov 01; 59(3):435-9. PubMed ID: 7927954
    [Abstract] [Full Text] [Related]

  • 6. Heterogeneity of melanoma antigen-1 (MAGE-1) gene and protein expression in malignant melanoma.
    Zuber M, Spagnoli GC, Kocher T, Lüscher U, Schaefer C, Noppen C, Gudat F, Harder F, Heberer M.
    Eur Surg Res; 1997 Nov 01; 29(5):403-10. PubMed ID: 9323494
    [Abstract] [Full Text] [Related]

  • 7. Immunophenotyping of melanomas for tyrosinase: implications for vaccine development.
    Chen YT, Stockert E, Tsang S, Coplan KA, Old LJ.
    Proc Natl Acad Sci U S A; 1995 Aug 29; 92(18):8125-9. PubMed ID: 7667256
    [Abstract] [Full Text] [Related]

  • 8. Melanoma patients immunized with melanoma cell vaccine induce antibody responses to recombinant MAGE-1 antigen.
    Hoon DS, Yuzuki D, Hayashida M, Morton DL.
    J Immunol; 1995 Jan 15; 154(2):730-7. PubMed ID: 7814879
    [Abstract] [Full Text] [Related]

  • 9. Serological analysis of Melan-A(MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas.
    Chen YT, Stockert E, Jungbluth A, Tsang S, Coplan KA, Scanlan MJ, Old LJ.
    Proc Natl Acad Sci U S A; 1996 Jun 11; 93(12):5915-9. PubMed ID: 8650193
    [Abstract] [Full Text] [Related]

  • 10. Detection of MAGE-4 protein in lung cancers.
    Shichijo S, Hayashi A, Takamori S, Tsunosue R, Hoshino T, Sakata M, Kuramoto T, Oizumi K, Itoh K.
    Int J Cancer; 1995 Jun 22; 64(3):158-65. PubMed ID: 7622303
    [Abstract] [Full Text] [Related]

  • 11. Cloning and analysis of MAGE-1-related genes.
    Ding M, Beck RJ, Keller CJ, Fenton RG.
    Biochem Biophys Res Commun; 1994 Jul 15; 202(1):549-55. PubMed ID: 8037761
    [Abstract] [Full Text] [Related]

  • 12. Seroreactivity against MAGE-A and LAGE-1 proteins in melanoma patients.
    Usener D, Gerhardt A, Schadendorf D, Eichmüller S.
    Br J Dermatol; 2003 Aug 15; 149(2):282-8. PubMed ID: 12932233
    [Abstract] [Full Text] [Related]

  • 13. Molecular cloning and expression analysis of feline melanoma antigen (MAGE) obtained from a lymphoma cell line.
    Ma Z, Khatlani TS, Li L, Sasaki K, Okuda M, Inokuma H, Onishi T.
    Vet Immunol Immunopathol; 2001 Dec 15; 83(3-4):241-52. PubMed ID: 11730932
    [Abstract] [Full Text] [Related]

  • 14. Direct selection of a human antibody fragment directed against the tumor T-cell epitope HLA-A1-MAGE-A1 from a nonimmunized phage-Fab library.
    Chames P, Hufton SE, Coulie PG, Uchanska-Ziegler B, Hoogenboom HR.
    Proc Natl Acad Sci U S A; 2000 Jul 05; 97(14):7969-74. PubMed ID: 10884427
    [Abstract] [Full Text] [Related]

  • 15. Establishment of an enzyme-linked immunosorbent assay (ELISA) for measuring cellular MAGE-4 protein on human cancers.
    Shichijo S, Tsunosue R, Kubo K, Kuramoto T, Tanaka Y, Hayashi A, Itoh K.
    J Immunol Methods; 1995 Oct 12; 186(1):137-49. PubMed ID: 7561142
    [Abstract] [Full Text] [Related]

  • 16. Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patients.
    Valmori D, Liénard D, Waanders G, Rimoldi D, Cerottini JC, Romero P.
    Cancer Res; 1997 Feb 15; 57(4):735-41. PubMed ID: 9044853
    [Abstract] [Full Text] [Related]

  • 17. Cloning and expression of the gene for the melanoma-associated ME20 antigen.
    Maresh GA, Marken JS, Neubauer M, Aruffo A, Hellström I, Hellström KE, Marquardt H.
    DNA Cell Biol; 1994 Feb 15; 13(2):87-95. PubMed ID: 8179825
    [Abstract] [Full Text] [Related]

  • 18. CT10: a new cancer-testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational-difference analysis.
    Güre AO, Stockert E, Arden KC, Boyer AD, Viars CS, Scanlan MJ, Old LJ, Chen YT.
    Int J Cancer; 2000 Mar 01; 85(5):726-32. PubMed ID: 10699956
    [Abstract] [Full Text] [Related]

  • 19. Expression of MAGE genes in primary and metastatic cutaneous melanoma.
    Brasseur F, Rimoldi D, Liénard D, Lethé B, Carrel S, Arienti F, Suter L, Vanwijck R, Bourlond A, Humblet Y.
    Int J Cancer; 1995 Nov 03; 63(3):375-80. PubMed ID: 7591235
    [Abstract] [Full Text] [Related]

  • 20. Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer.
    Groeper C, Gambazzi F, Zajac P, Bubendorf L, Adamina M, Rosenthal R, Zerkowski HR, Heberer M, Spagnoli GC.
    Int J Cancer; 2007 Jan 15; 120(2):337-43. PubMed ID: 17066423
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.